TA121 Glioma (newly diagnosed and high grade) - carmustine implants and temozolomide: understanding NICE guidance

The summary of the key recommendations of the technology appraisal on Glioma (newly diagnosed and high grade) - carmustine implants and temozolomide. It is written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets or any other suitable publication.